Formulation possibilities
Investigating approaches to solubility, stability, and pharmaceutical formulation.
Pharmaceutical delivery technology
A Small Sphere.
A World of Possibilities.
Discover how a distinctive hollow, porous architecture is opening new possibilities in pharmaceutical formulation and drug delivery.
Video overview
A closer look at the technology behind the possibilities.
In just 90 seconds, explore what makes SpheroFill's porous-wall hollow glass microspheres distinctive—and why their architecture invites further investigation.
The SpheroFill platform
Engineered architecture.
Expanding possibilities.
SpheroFill's porous-wall hollow glass microspheres combine a distinctive internal structure with surfaces that can be engineered for research into pharmaceutical applications.
Explore the architecture that makes this platform an intriguing subject for formulation and delivery research.
Explore the Five Technology Pillars
Porous architecture
Interconnected wall pores offer pathways for molecular transport.
Hollow interior
An internal cavity offers space to investigate compound loading.
Engineerable surface
Surface chemistry creates opportunities to study material interactions.
Versatile platform
A single architecture invites exploration across multiple formulation concepts.
Manufacturing development
Process consistency and scale-up are important areas for continuing work.
Potential applications
Exploring what this platform could make possible.
From formulation challenges to site-specific delivery concepts, SpheroFill is investigating where this distinctive architecture may open new possibilities across pharmaceutical development.
Localized delivery concepts
Exploring the potential for site-specific therapeutic delivery.
Release opportunities
Investigating approaches to sustained and tunable delivery.
Scientific foundations
Built on research.
Expanding through continued investigation.
Our work draws on published research, patented innovations, and ongoing scientific investigation. Explore the scientific foundation of the platform through our published research and patents.
Research
Scientific investigations of porous-wall hollow glass microsphere structure and potential applications.
Patents
Intellectual property addressing microsphere technologies and applications.
Development
Continuing research to refine understanding and evaluate emerging possibilities.
SpheroFill Insights · Podcast
Tiny Bubbles, Big Possibilities.
Discover the origins of porous-wall hollow glass microspheres, what makes their architecture distinctive, and the scientific questions inspiring new approaches to drug delivery.
Episode 1 · Introducing Porous-Wall Hollow Glass Microspheres
About SpheroFill
Meet the leadership team.
Bringing together experience in clinical medicine, materials science, and regenerative medicine, SpheroFill was founded to explore the biomedical possibilities of porous-wall hollow glass microspheres.
Co-founder
Paul M. Weinberger, MD
Interim CEO
Physician-scientist, fellowship-trained laryngologist, and healthcare executive. Dr. Weinberger combines clinical research and health-system leadership with experience translating biomedical technologies and developing SpheroFill's intellectual property.
Co-founder
George Wicks, PhD
VP Research & CTO
Materials scientist and former Savannah River National Laboratory senior researcher. Dr. Wicks brings decades of experience in glass and ceramic science, including the origins and engineering of porous-wall hollow glass microspheres.
Co-founder
William (Dave) Hill, PhD
Executive VP & CSO
Biomedical scientist with extensive experience in regenerative medicine, stem-cell biology, and translational research. Dr. Hill connects SpheroFill's materials platform with opportunities for biological investigation and pharmaceutical development.
Leadership expansion
Coming Soon
Pharmaceutical Business Leadership
We are in the process of adding seasoned pharmaceutical business leadership to support partnerships, strategy, and commercialization.
Let's explore what's next
A platform for collaboration.
A path to impact.
We welcome conversations with pharmaceutical partners, scientific collaborators, and investors who share our interest in advancing this technology.
For pharmaceutical partners
Explore development opportunities, collaborative research, and potential partnerships.
Start a conversationFor investors
Learn more about our technology, strategy, and potential opportunities.
Discuss the opportunityConnect with SpheroFill
Let's start a conversation.
Interested in the science, exploring a partnership, or learning about SpheroFill? We'd welcome the opportunity to connect.